Novo CEO pressed by Senate to chop selling prices of weight problems, diabetic issues medication CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would contemplate new talks with insurers in regards to the record costs of Wegovy and copyright if they pledge to help keep the medicines on their formularies. https://manuelvusro.thekatyblog.com/29774142/what-does-healthcare-news-mean